Global Biopharmaceuticals Market
The global Biopharmaceuticals market was valued at USD 385.63 Bn in 2020 which expected to reach USD 670.90 Bn by 2027 at a CAGR 8.23% from 2020-2027.
Biopharmaceuticals are substances with a high therapeutic value that are made from living organisms such as microorganisms and animal cells. Biologics and biotech drugs are two terms for large, complex molecular drugs.
Market Drivers
Growing acceptance and massive market demand for Biopharmaceuticals.
The most substantial factor driving the growth for this market is the huge market demand for biopharmaceuticals owing to the growing chronic diseases and rising geriatric population.
The global Biopharmaceutical Market is also driven by the planned investment in bio drugs research and development along with the marketing of innovative healthcare solutions, like new medicines.
Moreover, rapid advancement for bringing diversified new bioprocessing facilities and players by Biosimilars is also drive the market growth..
Market Restraints
The significant challenging factor for the market growth is stringent pharmaceutical protocols faced by the health professionals, biopharmaceutical companies & stakeholders. Moreover, investment are very high within the market, which is likely to restrain market growth.
COVID-19 Impact on the Biopharmaceuticals Market
The COVID-19 internationally is likely to have a substantial impact on the biopharmaceutical industry. Most biopharmaceutical companies are motivated widely for the development of vaccines against the SARS-CoV2 virus.
Some of the candidates are traditional-type vaccines like inactivated and attenuated products; on the other hand, most of the vaccine candidates being developed are advanced DNA, RNA, and protein subunit vaccines. This factor is anticipated to boost the growth of the biopharmaceuticals market over the pandemic.
Market Segmentation
The Global Biopharmaceuticals Market is segmented into Type, Application. By Type such as Monoclonal Antibody, Interferon, Insulin, Growth and Coagulation Factor, Erythropoietin, Vaccine, Hormone, Others. Further, market is segmented into By Application such as Oncology , Blood Disorder , Metabolic Disease , Infectious Disease, Cardiovascular Disease, Neurological Disease, Immunology, Other Applications.
Regional Analysis
Global Biopharmaceuticals Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. Asia Pacific is expected to have the highest CAGR. Due to increased R&D investment, increased adoption and availability of biopharmaceuticals for disease treatment, and increased disease diagnosis awareness, the Asia-Pacific region is expected to grow significantly in the future. Furthermore, because the developed markets are comparatively saturated, this region presents exceptional opportunities for venture capitalists and investors.
Key Players
Various key players are listed in this report such as Abbott Laboratories, Amgen Inc, Biogen Inc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd, Johnson & Johnson, Merck & Co., Inc, Novo Nordisk A/S, Pfizer Inc., Sanofi
Market Taxonomy
By Type
By Application
By Region
Key Questions Addressed by the Report
Global Biopharmaceuticals Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Biopharmaceuticals Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Biopharmaceuticals Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global Biopharmaceuticals Market Share Analysis, By Type
5.3 Global Biopharmaceuticals Market Size and Forecast, By Type
5.3.1 Monoclonal Antibody
5.3.2 Interferon
5.3.3 Insulin
5.3.4 Growth and Coagulation Factor
5.3.5 Erythropoietin
5.3.6 Vaccine
5.3.7 Hormone
5.3.8 Others
6 Global Biopharmaceuticals Market, By Application
6.1 Y-o-Y Growth Comparison, By Application
6.2 Global Biopharmaceuticals Market Share Analysis, By Application
6.3 Global Biopharmaceuticals Market Size and Forecast, By Application
6.3. 1 Food Transportation
6.3.2 Coal Transportation
6.3.3 Steel Transportation
6.3.4 Others
7 Global Biopharmaceuticals Market, By Region
7.1 Global Biopharmaceuticals Market Share Analysis, By Region
7.2 Global Biopharmaceuticals Market Share Analysis, By Region
7.3 Global Biopharmaceuticals Market Size and Forecast, By Region
8 North America Biopharmaceuticals Market Analysis and Forecast (2021-2027)
8.1 Introduction
8.2 North America Biopharmaceuticals Market Share Analysis, By Type
8.3 North America Biopharmaceuticals Market Size and Forecast, By Application
8.4 North America Biopharmaceuticals Market Size and Forecast, By Country
8.5.1 U.S.
8.6.2 Canada
9.7.3 Mexico
9 Europe Biopharmaceuticals Market Analysis and Forecast (2021-2027)
9.1 Introduction
9.2 Europe Biopharmaceuticals Market Share Analysis, By Type
9.3 Europe Biopharmaceuticals Market Size and Forecast, By Application
9.4 Europe Biopharmaceuticals Market Size and Forecast, By Country
9.5.1 Germany
9.6.2 France
9.7.3 UK
9.8.4. Rest of Europe
10 Asia Pacific Biopharmaceuticals Market Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 Asia Pacific Biopharmaceuticals Market Share Analysis, By Type
10.3 Asia Pacific Biopharmaceuticals Market Size and Forecast, By Application
10.4 Asia Pacific Biopharmaceuticals Market Size and Forecast, By Country
10.5.1 China
10.6.2 Japan
10.7.3 India
10.8.4. Rest of Asia Pacific
11 Latin America Biopharmaceuticals Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Latin America Biopharmaceuticals Market Share Analysis, By Type
11.3 Latin America Biopharmaceuticals Market Size and Forecast, By Application
11.4 Latin America Biopharmaceuticals Market Size and Forecast, Country
11.5.1. Brazil
11.6.2. Rest of Latin America
12 Middle East Biopharmaceuticals Market Analysis and Forecast (2021-2027)
12.1 Introduction
12.2 Middle East Biopharmaceuticals Market Share Analysis, By Type
12.3 Middle East Biopharmaceuticals Market Size and Forecast, By Application
12.4 Middle East Biopharmaceuticals Market Size and Forecast, By Country
12.5.1. Saudi Arabia
12.6.2. UAE
12.7.3. Egypt
12.8.4. Kuwait
12.9.5. South Africa
13 Competitive Analysis
13.1 Competition Dashboard
13.2 Market share Analysis of Top Vendors
13.3 Key Development Strategies
14Company Profiles
14.1 Abbott Laboratories
14.1.1 Overview
14.1.2 Offerings
14.1.3 Key Financials
14.1.4 Business Segment & Geographic Overview
14.1.5 Key Market Developments
14.1.6 Key Strategies
14.2. Amgen Inc
14.2.1 Overview
14.2.2 Offerings
14.2.3 Key Financials
14.2.4 Business Segment & Geographic Overview
14.2.5 Key Market Developments
14.2.6 Key Strategies
14.3. Biogen Inc
14.3.1 Overview
14.3.2 Offerings
14.3.3 Key Financials
14.3.4 Business Segment & Geographic Overview
14.3.5 Key Market Developments
14.3.6 Key Strategies
14.4 Eli Lilly and Company
14.4.1 Overview
14.4.2 Offerings
14.4.3 Key Financials
14.4.4 Business Segment & Geographic Overview
14.4.5 Key Market Developments
14.4.6 Key Strategies
14.5 F. Hoffmann-La Roche Ltd.
14.5.1 Overview
14.5.2 Offerings
14.5.3 Key Financials
14.5.4 Business Segment & Geographic Overview
14.5.5 Key Market Developments
14.5.6 Key Strategies
14.6 Johnson & Johnson
14.6.1 Overview
14.6.2 Offerings
14.6.3 Key Financials
14.6.4 Business Segment & Geographic Overview
14.6.5 Key Market Developments
14.6.6 Key Strategies
14.7 Merck & Co., Inc
14.7.1 Overview
14.7.2 Offerings
14.7.3 Key Financials
14.7.4 Business Segment & Geographic Overview
14.7.5 Key Market Developments
14.7.6 Key Strategies
14.8 Novo Nordisk A/S
14.8.1 Overview
14.8.2 Offerings
14.8.3 Key Financials
14.8.4 Business Segment & Geographic Overview
14.8.5 Key Market Developments
14.8.6 Key Strategies
14.9 Pfizer Inc.
14.9.1 Overview
14.9.2 Offerings
14.9.3 Key Financials
14.9.4 Business Segment & Geographic Overview
14.9.5 Key Market Developments
14.9.6 Key Strategies
14.10 Sanofi
14.10.1 Overview
14.10.2 Offerings
14.10.3 Key Financials
14.10.4 Business Segment & Geographic Overview
14.10.5 Key Market Developments
14.10.6 Key Strategies
